🔎 Trials Near Me

መነሻ › ከባድ ሰውነት › Texas › Austin

በAustin፣ TX ለከባድ ሰውነት የሚደረጉ ክሊኒካዊ ጥናቶች

ለከባድ ሰውነት የሚደረጉ 20 ጥናቶች በAustin እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Elligo Clinical Research Center /ID# 282166, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Diabetes & Endocrinology, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07668414

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Dell Children's Medical Center - PIN, Austin
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • IMA Clinical Research Austin, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • FutureSearch Trials of Neurology, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
እድሜ ከ45 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • IMA Clinical Research Austin, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
  • The University of Texas at Austin, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AURORA-1 Clinical Site, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AURORA-2 Clinical Site, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Austin Heart, Austin
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3ጤናማ ተሳታዮች ይቀበላሉ
  • ACCOMPLISH-2 Research Site, Austin
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • IMA Clinical Research Austin, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Elligo Clinical Research Center, Austin
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Elligo Clinical Research Center, Austin
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07684144

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Austin Heart, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Elligo Clin Res Centre, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Corxel Investigational Site, Austin
እድሜ ከ18 እስከ 55 · ሴቶች · የተሻሻለው በ17 ጁን 2026 · NCT07652047

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Dell Pediatric Research Center, Austin
  • University of Texas at Austin, Austin
እድሜ ከ30 እስከ 60 · ሴቶች · የተሻሻለው በ9 ጁን 2026 · NCT07480109

በሌሎች ከተሞች ለከባድ ሰውነት የሚደረጉ ጥናቶች

በAustin ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።